全文获取类型
收费全文 | 2248篇 |
免费 | 143篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 161篇 |
妇产科学 | 26篇 |
基础医学 | 231篇 |
口腔科学 | 60篇 |
临床医学 | 228篇 |
内科学 | 451篇 |
皮肤病学 | 28篇 |
神经病学 | 61篇 |
特种医学 | 480篇 |
外科学 | 173篇 |
综合类 | 35篇 |
预防医学 | 139篇 |
眼科学 | 16篇 |
药学 | 104篇 |
中国医学 | 3篇 |
肿瘤学 | 199篇 |
出版年
2021年 | 22篇 |
2020年 | 16篇 |
2019年 | 17篇 |
2018年 | 32篇 |
2017年 | 20篇 |
2016年 | 29篇 |
2015年 | 43篇 |
2014年 | 42篇 |
2013年 | 76篇 |
2012年 | 67篇 |
2011年 | 48篇 |
2010年 | 91篇 |
2009年 | 78篇 |
2008年 | 69篇 |
2007年 | 55篇 |
2006年 | 58篇 |
2005年 | 40篇 |
2004年 | 44篇 |
2003年 | 33篇 |
2002年 | 44篇 |
2001年 | 29篇 |
2000年 | 41篇 |
1999年 | 38篇 |
1998年 | 142篇 |
1997年 | 120篇 |
1996年 | 126篇 |
1995年 | 92篇 |
1994年 | 81篇 |
1993年 | 84篇 |
1992年 | 27篇 |
1991年 | 33篇 |
1990年 | 27篇 |
1989年 | 68篇 |
1988年 | 47篇 |
1987年 | 56篇 |
1986年 | 56篇 |
1985年 | 55篇 |
1984年 | 27篇 |
1983年 | 36篇 |
1982年 | 36篇 |
1981年 | 24篇 |
1980年 | 42篇 |
1979年 | 18篇 |
1978年 | 22篇 |
1977年 | 19篇 |
1976年 | 26篇 |
1975年 | 29篇 |
1974年 | 10篇 |
1973年 | 10篇 |
1970年 | 9篇 |
排序方式: 共有2413条查询结果,搜索用时 453 毫秒
1.
Sundaram Kavin Piuzzi Nicolas S. Patterson Brendan M. Stearns Kim L. Krebs Viktor E. Mont Michael A. 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2020,30(3):447-453
European Journal of Orthopaedic Surgery & Traumatology - The goals of this study were to compare patient satisfaction and wound-related complications in patients receiving 2-octyl cyanoacrylate... 相似文献
2.
Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies. 总被引:1,自引:0,他引:1
Heather A Jacene Takayoshi Ishimori James M Engles Sophie Leboulleux Vered Stearns Richard L Wahl 《Journal of nuclear medicine》2006,47(6):950-956
The purpose of this study was to evaluate the effects of pegfilgrastim, a long-acting granulocyte colony-stimulating factor, on the normal biodistribution of (18)F-FDG in an animal model and in humans. METHODS: Two groups of 12 rats received a single subcutaneous injection of either normal saline or pegfilgrastim. One, 7, 14, and 21 d after injection, biodistribution studies were performed 1 h after (18)F-FDG injection. Sixteen breast cancer patients underwent baseline (18)F-FDG PET/CT and, approximately 1 wk after receiving 1 dose of docetaxel and adjunctive pegfilgrastim, follow-up (18)F-FDG PET/CT (scan 2). Standardized uptake values corrected for lean body mass (SUL) were determined for several normal organs before and after therapy. RESULTS: In rats, bone marrow (18)F-FDG uptake (standardized uptake value) was higher in the pegfilgrastim group 1 d after injection (mean +/- SD, 8.3 +/- 4.1 vs. 2.5 +/- 0.2, P < 0.05), whereas (18)F-FDG uptake in blood was lower (0.41 +/- 0.06 vs. 0.49 +/- 0.01, P < 0.05). In patients, mean SUL was higher in bone marrow (4.49 +/- 1.50 vs. 1.33 +/- 0.22, P < 0.0001), spleen (3.29 +/- 0.83 vs. 1.23 +/- 0.23, P < 0.0001), and liver (1.45 +/- 0.25 vs. 1.31 +/- 0.23, P = 0.01) but lower in brain (4.18 +/- 0.76 vs. 5.14 +/- 1.44, P < 0.01) on scan 2 than on the baseline scan. CONCLUSION: In both the animal model and humans, pegfilgrastim markedly increased bone marrow uptake of (18)F-FDG and reduced (18)F-FDG uptake in some normal tissues. These profound alterations in (18)F-FDG biodistribution induced by pegfilgrastim must be considered when one is evaluating quantitative (18)F-FDG PET scans for tumor response to therapy. 相似文献
3.
JA HYEON KU CHEOL KWAK SEUNG-JUNE OH EUNSIK LEE SANG EUN LEE JAE-SEUNG PAICK 《International journal of urology》2004,11(7):489-493
BACKGROUND: Our aims in the present study were to estimate the influences of pain and urinary symptoms on quality of life, and to determine which of these two variables has the most predictive power with respect to quality of life in young men with chronic prostatitis-like symptoms. METHODS: Chronic prostatitis-like symptoms were measured by the National Institutes of Health-Chronic Prostatitis Symptom Index. Of the 28,841 men aged 20 years who lived in the study community, 18,495 men (a response rate 64.1%) agreed to participate in the study. A total of 1057 men who complained of symptoms indicative of chronic prostatitis were included in the study. The influences of pain and urinary symptoms on quality of life were determined using logistic regression analysis. The receiver operating characteristic (ROC) curve was used to estimate the predictive ability of each of these variables with respect to quality of life. RESULTS: Results from multivariate analysis showed that both pain and urinary symptoms were associated with an increased likelihood of impaired quality of life, although pain contributed more to a reduced quality of life than urinary symptoms. Relative to men who experienced mild pain, men who experienced moderate pain had a 3.9-fold risk of poor quality of life (odds ratio [OR], 3.87; 95% confidence interval [CI], 2.86-5.23; P < 0.001) and those who experienced severe pain had a 15.7-fold risk of reduced quality of life (OR, 15.68; 95% CI, 6.59-37.35; P < 0.001). Moderate urinary symptoms were associated with a 1.4-fold risk of bother (OR, 1.41; 95% CI, 1.01-1.99; P < 0.001) and severe urinary symptoms were associated with 2.4-fold risk (OR, 2.39; 95% CI, 1.37-4.12; P < 0.001), relative to mild urinary symptoms. Comparison of the effects of pain and urinary symptoms showed that pain severity had the most predictive power for bother, quality of life, and quality-of-life impact. The areas under the ROC curves for bother, quality of life, and quality-of-life impact were 71.3%, 69.3% and 72.5%, respectively. CONCLUSION: Urinary symptoms and pain might be associated with an increased likelihood of impaired quality of life in young men with chronic prostatitis-like symptoms. In addition, our findings suggest that pain severity is the most influential variable for determining quality of life in this population. 相似文献
4.
5.
6.
7.
8.
9.
10.